Assessment of outcome on treatment regimens containing anti-GD2 immunotherapy Clinical information from University of Michigan patients’ charts was obtained between 05/2012 and 06/2023. For every patient information on length of follow up, overall survival, mortality, treatment regimens, and time to progression on each treatment regimen was collected.
Get in touch with Meredith
Contact Meredith, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack